Viewing StudyNCT00373425



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00373425
Status: COMPLETED
Last Update Posted: 2015-09-17
First Post: 2006-09-07

Brief Title: A Study of Erlotinib Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma NSCLC Patients Who Have Epidermal Growth Factor Receptor EGFR Positive Tumors
Sponsor: OSI Pharmaceuticals
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer
Keywords:
Name View
Adjuvant Non-small Cell Lung Cancer View
Tarceva View
Early-stage Lung Cancer View
Adjuvant View
RADIANT View
NSCLC View
EGFR-positive tumor View
Stage IB Non-small Cell Lung Cancer View
Stage II Non-small Cell Lung Cancer View
Stage IIIA Non-small Cell Lung Cancer View